Prognosis of Patients With Intermediate Risk IPSS-R Myelodysplastic Syndrome Indicates Variable Outcomes and Need for Models Beyond IPSS-R

American Journal of Hematology - United States
doi 10.1002/ajh.25234
Full Text
Abstract

Available in full text

Categories
Hematology
Date
Authors
Publisher

Wiley

Related search

Prognostic Impact of IPSS-R and Chromosomal Translocations in 751 Korean Patients With Primary Myelodysplastic Syndrome

PLoS ONE
Multidisciplinary
2016English

Targeted Next-Generation Sequencing in Myelodysplastic Syndromes and Prognostic Interaction Between Mutations and IPSS-R

American Journal of Hematology
Hematology
2017English

Improving Revised International Prognostic Scoring System (IPSS-R) Pre-Allogeneic Stem Cell Transplant Does Not Translate Into Better Post-Transplant Outcomes for Patients With Myelodysplastic Syndromes: A Single Center Experience

Biology of Blood and Marrow Transplantation
TransplantationHematology
2018English

Optimizing Individual Treatment Outcomes in Men With Lower Urinary Tract Symptoms Using Storage Subscale Score/Total International Prostate Symptom Score (IPSS) as a New IPSS Ratio

Turkish Journal of Medical Sciences
Medicine
2014English

Effect of Depth of Electroacupuncture on the IPSS of Patients With Benign Prostatic Hyperplasia

Evidence-based Complementary and Alternative Medicine
Alternative MedicineComplementary
2019English

Targeting R-Loop-Associated ATR Response in Myelodysplastic Syndrome

Oncotarget
Oncology
2019English

BNSP: An R Package for Fitting Bayesian Semiparametric Regression Models and Variable Selection

R Journal
UncertaintyNumerical AnalysisStatisticsProbability
2019English

Comparative Analysis of Methods and Tools Applicability for Product and IPSS Development Based on Text Mining Techniques

Product Management & Development
2015English

Bayesian Testing, Variable Selection and Model Averaging in Linear Models Using R With BayesVarSel

R Journal
UncertaintyNumerical AnalysisStatisticsProbability
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy